ACLX Stock Analysis: Buy, Sell, or Hold?
ACLX - Arcellx, Inc. Common Stock
$68.31
0.05 (0.07%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
26d
Get Alerted When ACLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ACLX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: ACLX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: ACLX is currently trading at $68.31, which is considered slightly high relative to its 30-day fair value range of $63.77 to $68.68.
Technical Outlook: Technically, ACLX is in a strong downtrend. Immediate support is located at $66.00, while resistance sits at $76.50.
Market Sentiment: ACLX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $112.35 (+64.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ACLX is in a strong downtrend. Immediate support is located at $66.00, while resistance sits at $76.50.
Market Sentiment: ACLX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $112.35 (+64.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$63.77 -
$68.68
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 64.6% below Wall St target ($112.35)
Fair Price Analysis
30-Day Fair Range
$63.77 -
$68.68
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$66.00
Resistance Level
$76.50
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-20.15
Wall Street Target
$112.35
(+64.6%)
Revenue Growth (YoY)
-81.0%
Last updated: January 30, 2026 5:55 PM ET
Data refreshes hourly during market hours. Next update: 6:55 PM
Data refreshes hourly during market hours. Next update: 6:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Christopher Heery
SELL
21034 shares
2025-09-30
Christopher Heery
SELL
73 shares
2025-09-29
Christopher Heery
SELL
12396 shares
2025-09-26
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$65 | 60 HOLD |
Advanced ACLX Option Strategies
Professional options setups generated by AI based on today's ACLX price and gamma walls.
